Cargando…
Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
CONTEXT: Over the last few decades, extensive efforts have been made worldwide to develop nanomedicine delivery systems, especially via oral route for antidiabetic drugs. Absorption of insulin is hindered by epithelial cells of gastrointestinal tract, acidic gastric pH and digestive enzymes. EVIDENC...
Autores principales: | Gundogdu, Evren, Yurdasiper, Aysu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kowsar
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968979/ https://www.ncbi.nlm.nih.gov/pubmed/24696697 http://dx.doi.org/10.5812/ijem.8984 |
Ejemplares similares
-
Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs
por: Klatt, Sabine, et al.
Publicado: (2011) -
Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013) -
Cellular Uptake and Transport Mechanism of 6-Mercaptopurine Nanomedicines for Enhanced Oral Bioavailability
por: Zou, Yaru, et al.
Publicado: (2023) -
Nanomedicine for increasing the oral bioavailability of cancer treatments
por: Parodi, Alessandro, et al.
Publicado: (2021) -
Nanomedicines for Overcoming Cancer Drug Resistance
por: Hu, Tingting, et al.
Publicado: (2022)